Arcosa, Inc.
NYSEACA put/call ratio surges to 3.04, highest in 52 weeks and 4.3 standard deviations above average, signaling extreme hedging demand ahead of August 7 earnings despite stock rallying 31% weekly to $145.32.
Snapshot as of 25 Aug 2026
ACA reports Q2 results after the close on August 7, arriving at a 52-week high and carrying the most defensive options positioning in over a year. The options market is flashing an unusually loud warning. The put/call…
Arcosa walks into its Q1 2026 earnings call on a remarkable run — up 24% over the past month to $126.47, with the stock adding another 8.6% on Wednesday alone. The price action dominates the setup. That one-day move is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ACA — free to start on ORTEX.
Sign up for free →Open ACA on ORTEX